EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
US6509319B1 · kind B1 · utility
79Cited by
30References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2000 |
| Grant date | Jan 21, 2003 |
| Priority date | — |
| Expiry date | Oct 4, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/183
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition comprising at least one antifungal agent and at least one chelator, and a method for administering the pharmaceutical composition to a patient having a fungal infection. Another aspect provides a pharmaceutical composition comprising at least one chelator, at least one antifungal agent and at least one monoclonal antibody, wherein the monoclonal antibody is operatively attached to the chelator, and a method of administering this composition to a patient having a fungal infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.